evernorth glp-1 expands program to help employers curb costs Evernorth reaches deals with Novo

Searching for a mechanistic basis of age-induced memory impairment (AMI), we identified a brain-wide, age-associated upshift in the ultrastructural size and release function of presynaptic active zones (AZs) in the fruit fly Drosophila

GLP-1 drugs are a class of medications that mimic a hormone in your body that controls blood sugar and hunger

A Nature Medicine review published in January 2026 described GLP-1 medicines as "being prescribed to growing numbers of patients worldwide" for an expanding list of indications and noted that "new, more effective molecules with optimised pharmacokinetics produce greater weight loss and some may be more effective for various metabolic disorders, through incorporation of one or more additional peptide epitopes." The clinical pipeline includes 39 GLP-1 receptor agonist drugs in development across 34 companies, with only seven coming from the top 20 pharmaceutical firms

However, mainly clinical studies and clinically inclined reviews were included as core sources

Both speakers will be viewed via zoom in order to have a simulcast interactive program for all attendees